Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Joung H. Lee, MD is Professor and Head, Section of Skull Base Surgery, Department of Neurosurgery/Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center at Cleveland Clinic. He has established one of the largest meningioma programs in the world, evaluating more than 200 new meningioma patients annually and having accumulated one of the largest experiences in meningioma surgery, having surpassed over 1000 cases.
He has authored more than 100 publications and edited two books, including a comprehensive textbook on meningiomas (Springer-Verlag, 2008, 616 pages). Over the years, in addition to training Cleveland Clinic neurosurgery residents, he has trained over 20 research and clinical fellows in skull base surgery.
Dr. Lee was a recipient of Research Fellowship Award from the Neurosurgery Research and Education Foundation. His other honors include Thomas J. Watson Fellowship, Crutchfiled-Thomson-Gage Award, Razavi Clinical Scholarship Award and Mahaley Award (AANS Annual Meeting, 2002).
His clinical research in meningiomas has also been recognized with Synthes Awards (AANS Annual Meetings, 2007 & 2009, awarded to his fellows, Dr. B. Sade in 2007 and Dr. Jaesung Park in 2009), Integra Foundation Award (AANS Annual Meeting 2006, awarded to his fellow, Dr. B. Sade) and Integra Foundation Award (AANS Annual Meeting 2008). He is annually cited as one of the “Best Doctors in America.” He is also the former President (1999-2000) of the Ohio State Neurosurgical Society.
Dr. Lee received his medical degree from University of Southern California, and completed his neurosurgery residency at University of Virginia.
benign brain tumors (meningiomas, schwannomas), chiari malformation, Skull Base Surgery, trigeminal neuralgia, brain tumors, Meningiomas, Neurofibromatosis, Trigeminal Neuralgia, tumors of the brain and spine
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 10/3/2013, Dr. Lee has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.